Friday, 20 November 2026Read the signal. Shape what comes next.
Higher Ed Signal
Get the Signal Brief
Wide view of a canal lined with palm trees and grass under a hazy sky, in Benghazi, Libya.

Institutional development · Research, innovation and assessment · Libya

Benghazi researcher co-authors PLOS ONE protocol on metformin in gestational diabetes

Professor Mahmoud Werfalli of Libya's University of Benghazi is a co-author of an international study protocol, published in PLOS ONE, on metformin's anti-inflammatory effects in gestational diabetes.

Photo: WisiW / Wikimedia Commons, CC BY-SA 4.0

Why it matters: The University of Benghazi counts a co-authorship in an international PLOS ONE protocol on metformin and gestational diabetes among its research outputs.

The University of Benghazi said Professor Mahmoud Werfalli, one of its researchers, has co-authored an international study protocol published in the journal PLOS ONE.

According to the university, the protocol sets out a study of the anti-inflammatory effects of metformin, a diabetes drug, in gestational diabetes.

The university said the study will use a systematic review and meta-analysis, methods that pool findings from existing research.

Editor’s view

Joseph Lopez, Collaboration Editor

The University of Benghazi reports that Professor Mahmoud Werfalli is a co-author of this international protocol, which describes a planned systematic review and meta-analysis of metformin's anti-inflammatory effects in gestational diabetes.

Keep reading

See all